Delivery Order SPE2DB24D2101-SPE2DB24FKGHM

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $10,394.69, is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a...
The U.S. Defense Logistics Agency (DLA) awarded a $7,349.07 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $6,998.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of Orencia ClickJect 125 mg/ml pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,035.48 fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,022.20 firm-fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $13,491.42 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ORENCIA CLICKJECT 125 MG/ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,248.51 firm fixed-price delivery order is for the supply of ORENCIA CLICKJECT 125 MG/MLML, a specialty medication. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $11,766.46 to supply ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. The contract has a performance period through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,440.74, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML medical products. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The Defense Logistics Agency (DLA) awarded a $7,001.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGHM
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a $52,979.25 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is set to expire on September 6, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical medications and medical supplies to various federal agencies and healthcare providers.

Generated 12/5/24, 9:46 AM